Cargando…
Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types
The most prominent pathological features of multiple sclerosis (MS) are demyelination and neurodegeneration. The exact pathogenesis of MS is unknown, but it is generally regarded as a T cell-mediated autoimmune disease. Increasing evidence, however, suggests that other components of the immune syste...
Autores principales: | Greer, Judith M., Trifilieff, Elisabeth, Pender, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473150/ https://www.ncbi.nlm.nih.gov/pubmed/32973782 http://dx.doi.org/10.3389/fimmu.2020.01891 |
Ejemplares similares
-
YY1 negatively regulates mouse myelin proteolipid protein (Plp1) gene expression in oligodendroglial cells
por: Zolova, Olga E, et al.
Publicado: (2011) -
PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations
por: Cloake, Nancy C., et al.
Publicado: (2018) -
Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis
por: Greer, Judith M.
Publicado: (2013) -
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)
por: Kaushansky, Nathali, et al.
Publicado: (2012) -
PLP-Dependent Enzymes
por: Paiardini, Alessandro, et al.
Publicado: (2014)